CA3 treatment (1 μM; 48 h) in PC cells reduced the protein expression levels of PAF1, YAP1, TEAD4, CD133 (cancer stem cell marker), and SOX9 (pancreatic ductal marker) (Fig. 4A–C). This evidence concerns the gene TEAD4 and pachyonychia congenita.